Field of the Invention This invention relates to compositions containing an azole and an amine oxide and their use as wood preservative and waterproofing compositions and as fungicides in agricultural products.

Background of the Invention Azoles are generally known to be effective as wood preservatives. Azole compounds are registered with the US Environmental Protection Agency (EPA) for use in wood protection treatment to buildings, forest products, finished wood products, log houses, wooden aquatic structures, wooden containers, and pressure treated forest products. Azoles are also used in industrial preservation applications and agriculture applications to protect plants, fruits, vegetables, cereal crops and sugar corps from fungal attack.

Azole compounds are lipophilic, due to their organic nature, and have good solubility in organic medium. However, they typically have poor solubility in aqueous solutions. According to"The Pesticide Manual, 11th Edition", C. D. S. Tomlin, editor, published by the British Crop Protection Council, UK (1997), the solubility of propiconazole in water is 100 ppm at 20° C, and that of tebuconazole in water is 36 ppm at 20° C. A number of wood preservation concentrates have recently been developed to circumvent the water solubility problem.

DE 19648888 describes water-thinned wood preservative concentrates containing at least 5% triazole fungicide in an aqueous benzalkonium halide solution, e. g., a 50% aqueous (C, 2, 4 alkyl) benzyldimethyl ammonium chloride solution.

WO 98/18321 describes a microbicide microemulsion containing a solvating surfactant selected from alkoxylated castor oil, alkoxylated hydrogenated castor oil and an alkyoxylated rosin.

WO 98/00008 describes a liquid pesticidal composition containing azole compounds in an organic solvent and as surfactants (a) a castor oil ethoxylate having 30-50

mole ethoxylate, (b) a branched C8-C, s alcohol ethoxylate having 5-10 mole ethoxylate, and (c) a tristyrene phenol ethoxylate having 8-30 mole ethoxylate or its phosphate or salt.

DE 4441672 describes wood preservative compositions containing a dimethylalkylamine, an aliphatic C-C, dicarboxylic acid, propylene glycol and a triazole compound.

There is a continuing need for improved azole wood preservative and waterproofing compositions and azole antifungal compositions.

Summarv of the Invention Applicants have discovered that amine oxides enhance the performance of azoles as fungicides and wood preservatives. Also, amine oxides have been found to provide waterproofing properties and enhance the uniform distribution and penetration of azoles into wood substrates. The present invention provides a composition comprising an amine oxide and an azole, such as a 1,2,4-triazole. The composition of the present invention may be incorporated into or be a wood preservative and waterproofing system, or agricultural product.

Another embodiment of the present invention is a method for preserving and/or waterproofing a wood substrate by applying the composition to the wood substrate.

Yet another embodiment is an article comprising a wood substrate and the composition of the present invention.

The invention also provides a method of controlling fungi comprising applying an effective amount of the composition of the present invention to the fungi or the area on which the fungi grow.

Detailed Description of the Invention The present invention provides a composition comprising an amine oxide and an azole. Surprisingly, the fungicidal activity of the azole/amine oxide composition is substantially greater than the sum of the fungicidal activities of the amine oxides and azole separately.

The amine oxide also enhances the uniform distribution and penetration of the azole into wood substrates and improves leach resistance. Furthermore, the azole compositions of the present invention have high water solubility and low volatility.

The compositions of the present invention are useful as wood preservatives for protecting wood from staining, discoloring, molding, rotting and losing its mechanical properties. Wood products which can be preserved with the composition include, but are not limited to, timber, lumber, railway tiles, telephone poles, fences, windows and doors,

plywood, particle board, oriented-strained board, chipboard, joinery, bridges and wood products which are generally used in houses, building, construction and carpentry.

The compositions are also useful in textile fibers, e. g., cotton and wool natural fibers and polyamide and polyester synthetic fibers; coatings, e. g., oil paints, dispersion paint, lacquers, and finishing stains; and adhesives and other materials which are degradable by fungi. The compositions may also advantageously be applied in the cellulose and paper industry, in particular to protect pulpwood for paper manufacture from fungal attack.

Additionally, the compositions are useful for industrial preservation to protect products from microbiological attack or degradation, which reduces or destroys their economic value. Examples of such products include, but are not limited to, latexes, adhesives, cellulose products, metal working fluids, coatings, and paint compositions.

The compositions of the present invention are effective against a broad range of fungi. Examples of such fungi include, but are not limited to, Ascomycetes (e. g., Venturia, Podosphaera, Erysiphe, Monilinia, Uncinula, Aureobasidium, Sclerophoma); Basidiomycetes (e. g., Hemileia, Rhizoctonia, Puccinia, Coniophora, Serpula, Poria, Uromyces, Gloeophyllum, Lentinus, Coriolus, Irpex); and fungi imperfecti (e. g., Botrytis, <BR> <BR> Helminthosporium, Rhynchosporium, Fusarium, Septoria, Cercospora, Alternaria, Pyricularia, Penicillium, Geotrichum).

The amine oxide may be a trialiphatic substituted amine oxide, an N alkylated cyclicamine oxide, a dialkylpiperazine di-N-oxide, an alkyldi (poly (oxyalkylene)) amine oxide, a dialkylbenzylamine oxide, a fatty amidopropyldimethyl amine oxide, a diamine oxide; a triamine oxide, or any combination of any of the foregoing. Preferably, the amine oxide includes at least one C8-C, 8 alkyl moiety.

Preferred trialiphatic substituted amine oxides have the formula RlR2R3Noo where R'is a linear, branched, cyclic or any combination thereof Cg to C40 saturated or unsaturated group; and R2 and R3 independently are linear, branched, or any combination thereof C, to C40 saturated or unsaturated groups. R', R2, and R3 independently may be alkyl, alkenyl, or alkynyl groups. More preferably, R'is a linear, branched, cyclic or any combination thereof Cg to C22 saturated or unsaturated group, such as coco, hydrogenated tallow, soya, decyl, hexadecyl, and oleyl; and R2 and R3 independently are linear, branched, or any combination thereof C, to C22 saturated or unsaturated groups, such as coco, hydrogenated tallow, soya, decyl, and hexadecyl.

A preferred trialiphatic substituted amine oxide is a dialkylmethylamine oxide having the formula R'R2CH3N<O, where R'and R2 are defined as above. Another preferred trialiphatic substituted amine oxide is an alkyldimethylamine oxide having the formula R' (CH3) 2N-0, where R'is defined as above. More preferred alkyldimethylamine oxides

have the formula R19(CH3)2N#O, where R'9 is a linear or branched C8-C, 8 alkyl or alkenyl.

Preferably, R'9 is a linear or branched C8-C, 6 alkyl. Alkyldimethylamine oxides are non-toxic and non-mutagenic surfactants. Suitable alkyldimethylamine oxides include, but are not limited to, a C, o alkyldimethylamine oxide, a C, 0-C14 alkyldimethylamine oxide, a C, 2-C, 6 alkyldimethylamine oxide, a C, 6-C, alkyldimethylamine oxide, and any combination of any of the foregoing.

Preferred N-alkylated cyclicamine oxides have the formula R4R5R6NX O where R4 is defined as R'above and R5 and R6 are linked to form a cyclic group. The cyclic group typically contains from 4 to 10 carbon atoms and may optionally contain oxygen, sulfur, nitrogen, or any combination of any of the foregoing. More preferred N-alkylated cyclicamine oxides include, but are not limited to, an alkylmorpholine N-oxide, a dialkylpiperazine di-N- oxide, and any combination of any of the foregoing.

Preferred alkylmorpholine N-oxides have the formula where R7 is defined as R'above. According to a more preferred embodiment, R'is a linear or branched Cg to C, 6 alkyl. Examples of preferred alkylmorpholine N-oxides include, but are not limited to, cetyl morpholine N-oxide and lauryl morpholine N-oxide.

Preferred dialkylpiperazine di-N-oxides have the formula where Ru ils defined as R'above and R9 is defined as R'above.

Preferred alkyldi (poly (oxyalkylene)) amine oxides have the formula where R'° is defined as R'above; R"and R'2 independently are H or CH3; and m and n independently are integers from about 1 to about 10.

Preferred dialkylbenzylamine oxides have the formula R13R14R15N#O, where R 13 is defined as R'above; R'4 is defined as R2 above; and Rl5 is benzyl. More preferred dialkylbenzylamine oxides include, but are not limited to, alkylbenzylmethylamine oxides having the formula R'3R'5CH3Noo where R'3 and R'5 are defined as above. According to a more preferred embodiment, R'3 is a linear or branched C8-CI2 alkyl.

Preferred fatty amidopropyldimethyl amine oxides have the formula

where R'6 is defined as R'above.

Preferred diamine oxides have the formula where R"is defined as R'above; and m is an integer from about 1 to about 10.

Preferred triamine oxides have the formula where Rl8 is defined as R'above; and m and n independently are integers from about 1 to about 10.

Long chain (C, 6 or greater) amine oxides, such as hexadecylamine oxides and hydrogenated tallow amine oxides, are particularly preferable for imparting waterproofing properties to the composition. Short chain (C, 4 and shorter) amine oxides aide in solubilizing the azole and long chain amine oxides.

The azole is preferably a 1,2,4-triazole. Suitable 1,2,4-triazoles include, but are not limited to, triadimefon, triadimenol, triazbutil, propiconazole, cyproconazole, difenoconazole, tebuconazole, myclobutanil, triadimenol, fenbuconazole, etaconazole, bromoconazole, flusiazole, uniconazole, diniconazole, bitertanol, hexaconazole, azaconazole, flutriafol, epoxiconazole, fluquinoconazole, tetraconazole, penconazole, and any combination of any of the foregoing. Preferred azoles include, but are not limited to triadimefon, propiconazole, cyproconazole, tebuconazole, myclobutanil, fenbuconazole, and any combination of any of the foregoing. More preferably, the azole is propiconazole, tebuconazole, or any combination of any of the foregoing. The azole may also be a benzimidazole, such as thiabendazole, benomyl, and carbendazim.

A preferred amine oxide/azole combination is a C, 0-C, 6 alkyl dimethylamine oxideoramixture of C, 0-C, 6 alkyl dimethylamine oxides with propiconazole, cyproconazole, tebuconazole, or a combination thereof. More preferred C, o-C, 6 alkyl dimethylamine oxides for these combinations include, but are not limited to, coco-dimethylamine oxide, a mixture of branched C, 0-CI4 alkyl dimethyl amine oxides, and any combination of any of the foregoing.

The composition may include a solvent, such as water and water miscible solvents, including, but not limited to, alcohols, glycols, esters, ethers, polyethers, amides, and any combination of any of the foregoing.

The weight ratio of amine oxide to azole broadly ranges from about 5000: 1 to about 0.1: 1 and preferably ranges from about 100: 1 to about 1: 1. According to one preferred embodiment, the weight ratio ranges from about 40: 1 to about 5: 1 and is more preferably about 20: 1.

According to one embodiment of the invention, the composition in concentrated form contains broadly from about 5 to about 100%, preferably from about 10 to about 50%, and more preferably from about 10 to about 35% by weight of combined amine oxide and azole based upon 100% weight of total composition.

Use dilutions of the composition typically comprise a fungicidally effective amount of azole and amine oxide. Generally, the use dilution comprises a fungicide enhancing effective amount of amine oxide, i. e., an amount of amine oxide sufficient to enhance the fungicidal efficacy of the azole. For wood applications, the use dilution may comprise a wood distribution, penetrating enhancing, waterproofing, and/or fungicide enhancing effective amount of amine oxide and a fungicidally effective amount of azole. Use dilutions preferably comprise from about 0.01 to about 5.0%, more preferably from about 0.1 to about 5.0%, and most preferably from about 0.5 to about 5.0% by weight of amine oxide, based upon 100% weight of total composition. Use dilutions preferably comprise from about 0.00001% (0.1 ppm) to about 2.0%, more preferably from about 0.0001% (1 ppm) to about 1.0%, and most preferably from about 0.0005% (5 ppm) to about 0.5% by weight of azole, based upon 100% weight of total composition.

The composition may be incorporated into or be a wood preservative and/or waterproofing system or an agricultural product.

Other adjuvants may be included in the composition as known to one of ordinary skill in the art. Examples of such adjuvants include, but are not limited to, thickeners, drying oils, anti-oxidants, UV absorbers, pigments, waxes, and any combination of any of the foregoing. Other biocides, fungicides and insecticides may be include in the composition. Any organic insecticide or fungicide that can be solubilized by an aqueous amine oxide solution is suitable for use in the present composition. Suitable insecticides include, but are not limited to, chloropyrifos, folpet, captafol, captan, pyrethroids, and any combination of any of the foregoing. Suitable fungicides include, but are not limited to, iodopropargyl butylcarbamate, tributyltin oxide, 2- (thiocyanomethylthio) benzothiazole, iodo- sulfones, azoles, isothiazalones, and any combination of any of the foregoing.

Another embodiment of the present invention is a method for preserving and/or waterproofing a wood substrate by applying the composition of the present invention to the wood substrate. The composition may be applied to the wood substrate by any method known to one of ordinary skill in the art. For example, the composition may be applied by treating the wood substrate under pressure or vacuum, in a thermal or dip system. Alternatively, it may be applied by a surface treatment, such as brushing, dipping, soaking, and spraying.

The invention also includes a method of controlling fungi comprising applying an effective amount of one or more compositions of the present invention. The term "controlling"as used herein includes, but is not limited to, inhibiting growth of fungi.

The composition of the present invention may be prepared by mixing the azole, amine oxide, solvents, and adjuvants. The mixture may be heated and/or stirred to expedite mixing.

Description of the Preferred Embodiments The following examples illustrate the invention without limitation. All parts and percentages are given by weight unless otherwise indicated.

The abbreviations"DMAO"and"BMAO"in the examples stand for dimethylamine oxide and benzyl methylamine oxide, respectively. The following ingredients were used in the examples: (a) branched alkyl (C, 0-C14) dimethylamine oxide (branched alkyl (Cl0- Cl4) DMAO), which is available as Barlox 12i from Lonza Inc. of Fair Lawn, NJ; (b) coco-alkyl (C, 2-C, 6) dimethylamine oxide (coco-DMAO) which is available as Barlox'12 from Lonza Inc. of Fair Lawn, NJ; (d) octyl dimethylamine oxide (octyl-DMAO), decyl dimethylamine oxide (decyl-DMAO), dodecyldimethylamine oxide (dodecyl-DMAO), tetradecyl dimethylamine oxide (tetradecyl-DMAO), hexadecyl dimethylamine oxide (hexadecyl- DMAO), octadecyl dimethylamine oxide (octadecyl-DMAO), which are available as FMBAO-8, Barlox# 10S, Barlox# 12S, Barlox# 14, Barlox# 16S, and BarloxX 18S, from Lonza Inc. of Fair Lawn, NJ; (e) coco-alkyl-di (hydroxyethyl) amine oxide and tallow-alkyl- di (hydroxyethyl) amine oxide which are available as Aromox C/12 and Aromox T/12 from Akzo Chemical of Chicago, IL ; (f) the other amine oxides described below can be prepared from the corresponding amine with hydrogen peroxide according to the procedure described in U. S.

Patent No. 5,486,315, which is herein incorporated by reference; (g) cyproconazole and propiconazole which are available from Janssen Pharmaceutica of Titusville, NJ; (h) fenbuconazole and myclobutanil which are available from Rohm and Haas of Spring House, PA; and (i) tebuconazole and triadimefon which are available from Bayer Corporation of Pittsburgh, PA.

Barlox 10S, 12,12i, 14, and 16S are 30% (w/w) aqueous solutions of their corresponding amine oxides. Barlox 18S and FMBAO-8 are 25% and 40% (w/w) aqueous solutions of their corresponding amine oxides, respectively. Barloxo 1 OS, 12,12i, and 14 and FMBAO-8 are liquids. Barlox 16S and 18S are a viscous liquid and a paste, respectively.

Example 1 1.06 g ofpropiconazole was dissolved in 16.88 g of 31.4% (w/w) coco-DMAO in water with stirring to form a solution containing about 29.5% by weight of coco-DMAO and about 5.89% by weight of propiconazole. The weight ratio of coco-DMAO to propiconazole was about 5: 1.

3.39 g of the propiconazole/coco-DMAO solution having a weight ratio of about 5: 1 was diluted with 96.61 g of water to form a clear solution containing about 1% by weight of coco-DMAO and about 0.05 g by weight of propiocnazole.

0.45 g of propiconazole was dissolved in 28.66 g of 31.4% (w/w) coco-DMAO (in water) and 15.86 g of water with stirring to form a clear solution containing about 20% by weight of coco-DMAO and 1 % by weight of propiconazole. The weight ratio of coco-DMAO to propiconazole was about 20: 1.

5.00 g of the propiconazole/coco-DMAO solution having a weight ratio of about 20: 1 was diluted with 95 g of water to form a clear solution containing about 1% by weight of coco-DMAO and about 0.05% by weight of propiconazole.

Example 2 The procedure in Example 1 was repeated except thatbranched alkyl (Cl0-Cl4) DMAO was substitued for coco-DMAO.

Example 3 1.06 g of tebuconazole was dissolved in 16.86 g of 31.4% (w/w) coco-DMAO in water with heating to from about 40 to about 50° C and stirring to form a clear, colorless solution containing about 29.5% by weight of coco-DMAO and about 5.89% by weight of tebuconazole. The weight ratio of coco-DMAO to tebuconazole was about 5: 1.

0.45 g of tebuconazole was dissolved in 28.66 g of 31.4% (w/w) coco-DMAO (in water) and 15.86 g of water with heating to from about 40 to about 50° C and stirring to form a clear solution containing about 20% by weight of coco-DMAO and 1 % by weight of tebuconazole. The weight ratio of coco-DMAO to tebuconazole was about 20: 1.5.00 g of the tebuconazole/coco-DMAO solution having a weight ratio of about 20: 1 was diluted with 95 g of water to form a clear solution containing about 1 % by weight of coco-DMAO and 0.05% by weight of tebuconazole.

Example 4 The procedure in Example 3 was repeated except that triadimefon was substituted for tebuconazole.

Example 5 20.0 g of dodecyl-DMAO in solid form (95% purity) was mixed well with 1.0 g of tebuconazole powder to obtain a solid white mixture.

1.05 g of the tebucoanzole/dodecyl-DMAO mixture was added to 98.95g of water to form a clear, colorless solution containing about 1% by weight of dodecyl-DMAO and about 0.05% by weight of tebuconazole.

Example 6 The procedure in Example 1 was repeated with the azoles and amine oxides in the amounts specified in Table 1 below. The solubility of the azoles in the solution is shown in Table 1.

Table 1 Solubility of Azoles in Amine Oxides Azole Amine Oxide % by weight % by weight of Soluble of Azole Amine Oxide Cyproconazole 5. 00 28.50 Yes Fenbuconazole 1. 00 29.70 Yes Myclobutanil 5. 00 28.50 Yes 28.50Propiconazole5.00 Yes Coco-DMAO Tebuconazole 3. 00 29.10 Yes Triadimefon 2. 50 29.25 Yes Cyproconazole 5. 00 28.50 Yes 29.70YesFenbuconazole1.00 28.50YesMyclobutanil5.00 Propiconazole Branched Alkyl 5. 00 28.50 Yes Tebuconazole (Clo-Cl4)-DMAO 3. 00 29.10 Yes Triadimefon 2. 50 29.25 Yes Cyproconazole 5. 00 28.50 Yes 29.70YesFenbuconazole1.00 28.50YesMyclobutanil5.00 Propiconazole 5. 00 28.50 Yes Cetyl-DMAO Tebuconazole 5. 00 29.10 Yes Triadimefon 2. 50 29.63 Yes Comparative Example 6A The solubility ofpropiconazole, tebuconazole, andtriadimefon (without amine oxide) in water is shown in Table 2 below."The Pesticide Manual, l 1th Edition", C. D. S.

Tomlin, editor, published by The British Crop Protection Council, UK (1997).

Table 2 Azole Apperance Solubility in watera Solubility in Waterb Cyproconazole White Powder 140 ppm/25°C 140 ppm at 22° C Fenbuconazole Off-White Powder 0.2 ppm/25°C 4 ppm at 25 ° C Myclobutanil Off-White Powder 142 ppm/25°C 142 ppm at 25 ° C Propiconazole Brown Oil 100 ppm/20°C 100 ppm at 20° C Tebuconazole White Powder 36 ppm/20°C 32 ppm at 20° cc Triadimefon White Powder 64 ppm/20°C 64 ppm at 20°C a."The Pesticide Manual, l 1th Edition", C. D. S. Tomlin, editor, published by The British Crop Protection Council, UK (1997). b. Material Safety Data Sheet of respective azoles. c. Also found in Bayer Technical Information Sheet No. N-107, Bayer Corporation of Pittsburgh, PA.

Comparative Example 6B Aqueous mixtures containing 1% by weight of propiconazole and 20% by weight of 4-methyl morpholine-N-oxide, pyridine N-oxide, trimethylamine oxide, or dimethylbenzylamine oxide were prepared. The weight ratio of amine oxide to propiconazole in each solution was about 20: 1. In all the solutions, the propiconazole was not soluble in the solution and oiled out at the bottom of the flask.

Example 7 A composition solution containing 5.0% by weight of propiconazole and 95% by weight of Barlox'12 was prepared. Barlox# 12 is an aqueous solution containing 30% by weight of coco-DMAO. This composition was stored at room temperature for 13 months.

NMR spectroscopy was used to analyze the sample. No decomposition of the composition was observed.

A composition solution containing 5.0% by weight of tebuconazole and 95% by weight of BarloxX 12 was prepared. This composition was stored at room temperature for 1 year. No decomposition of the composition was observed.

Example 8 The corrosivity of the aqueous azole/amine oxide solutions in Table 3 was determined as follows. Approximately 20 mL of each aqueous test solution was prepared containing 1 % by weight of amine oxide and 0.05% by weight of azole. The test solution was added to a Wheaton borosilicate glass scintillation vial having a polyethylene screw cap. A '/2"x 1 1/2"X 0.032" low carbon steel coupon with a 1/4"hole punched 1/4"from the top edge, available from Q-Panel Company of Cleveland, Ohio, was suspended from the cap via teflon coated clips. After suspension, the bottom edge of the coupon was approximately 1/16"to 3/32"above the bottom of the vial. The coupon was immersed in the solution and stored at room temperature. The coupon was observed for signs of corrosion after 24 hours, 2 weeks, and 24 days.

The results are shown in Table 3 below.

Table 3 Observation Observation Initial Observation Amineafter24after14Azole SolutionDays24 Hours Days Clear, No No Octyl-DMAO Propiconazole Colorless No Corrosion CorrosionCorrosion Clear, Decyl-DMAO Propiconazole Colorless No Corrosion Corrosion Corrosion Solution Dodecyl-Clear, nô DMAO Propiconazole Colorless No Corrosion Corrosion No Corrosion Solution Branched Alkyl clear, Slight edge Edge ColorlessNoCorrosioncorrosionon(C10-C14)Propiconazole Corrosion DMAO Solution coupon Clear, No No Coco-DMAO Propiconazole Colorless no Corrosion Corrosion Corrosion Solution Solution DMAO Propiconazole lightly No Corrosion Corrosion No Corrosion turbid Octadecyl- Turbid No PropiconazolePropiconazoleNo corrosion Corrosion DMAO Corrosion Clear,light nô Oleyl-DMAO Propiconazole yellow No Corrosion Corrosion No Corrosion Solution Dodecylbenzyl Clear, nô Doaecylbenzyl @@@@@, No Colorless No Corrosion No Corrosion methylamine Propiconazole Corrosion oxide Solution Cetyl Clear, No morpholine N-Propiconazole Colorless No Corrosion Corrosion No Corrosion oxide Solution Branched Alkyl Clear, nô Branched Alkyl @@@@, No (C10-C14)(C10-C14)Tebuconazole Colorless No Corrosion No Corrosion Corrosion DMAo Solution Clear, No No No Coco-DMAO Tebuconazole Colorless Corrosion Corrosion Corrosion Solution No No No Coco-DMAO triadimefon Colorless CorrosionCorrosionCorrosion Solution Comparative Example 8A The corrosivity of the solutions in Table 4 was determined by the procedure described in Example 8. The results are shown in Table 4 below.

Table 4 Observation Observation Observation Solution Initial Solution after 24 hours after 14 Days after 24 Days De-ionized water Clear, Coupon has Solution rusty Solution rusty Colorless black surface and coupon and coupon Solution rust colored rust colored 1% by weight of NP-1 Turbid Rusty, Orange Rusty, Orange Rusty, Orange Sapstain Control precipitation precipitation precipitation Chemical' 1 % by weight of Clear, Black Black Black didecyldimethyl Colorless corrosion precipitation, precipitation, ammonium chloride2 Solution corrosion on corrosion on coupon coupon surface surface 1 % by weight of Blue, clear Rust Rust Rust ammoniated copper solution precipitation precipitation, precipitation, quat, type D3 corrosion on corrosion on coupon edge coupon edge 1% by weight of alkyl Clear, light Coupon Coupon Coupon surface (C-C) yellow Solution surface black surface black, black, rust benzyldimethyl rust precipitation ammonium chloride'precipitation 1% by weight of Clear, No Corrosion No Corrosion No Corrosion didecyl dimethyl Colorless ammonium Solution '-NP-1 Sapstain Control Chemical is available from Kop-Coat Inc. of Pittsburgh, PA.

2 _ Didecyldimethyl ammonium chloride is available as Bardac 2280 from Lonza Inc.

3-Ammoniated copper quat, type D, is available from Chemical Specialties, Inc. of Charlotte, NC. It is prepared following the procedure described in"American Wood- Preservers'Association Standard", published by American Wood Preservers Association, pages 12-13 (1999).

4-Alkyl (C, 2-C, 6) benzyldimethyl ammonium chloride is available as Barquat 80-28 from Lonza Inc.

5-Didecyldimethyl ammonium carbonate can be prepared according to the procedure described in WO 94/28715.

Example 9 The corrosivity of the aqueous azole/amine oxide solutions in Table 5 on aluminum was determined as follows. Approximately 40 mL of each aqueous test solution was prepared containing 1% by weight of amine oxide and 0.05% by weight of azole. The test solution was added to a 8-dram borosilicate glass vial (25 mm outer diameter x 95 mm height, 32 mL) having a polyethylene screw cap. A 3"x 1/2"X l/16"aluminum coupon with a 1/4"hole punched 1/4"from the top edge and having a 120 grit surface, available from Metal Samples Co. of Munford, Alabama, was suspended fromthe cap viatefloncoated clips.

After suspension, the bottom edge of the coupon was approximately 1/16"to 3/32"above the bottom of the vial. The coupon was immersed in the solution and stored at about 50 ° C. The coupon was observed for signs of corrosion after 2 weeks and 8 months.

The results are shown in Table 5 below.

Table 5 Observation Amine Oxide Azole Initial Solution 8 Daysafter14 Months Clear, Colorless No Decyl-DMAO Propiconazole Corrosion SolutionCorrosion Branched alkyl Clear, Colorless No CorrosionPropiconazoleNo (C10-C14) DMAO Solution Corrosion Clear, Colorless No Coco-DMAO No Corrosion SolutionCorrosion clear, olorless No Coco-DMAO Tebuconazole No Corrosion SolutionCorrosion Clear, Colorless No Coco-DMAO Triadimefon No Corrosion SolutionCorrosion Homogeneous,No Hexadecyl-DMAO Propiconazole Corrosion Turbid Solution corrosion Homogeneous, No Octadecyl-DMAO Propiconazole No Corrosion Turbid Solution Corrosion Solution Cetyl morpholine Colorless CorrosionClear;TracePropiconazoleNo N-oxide Solution Sediments Clear, Light No Oleyl-DMAO Propiconazole Corrosion Yellow Solution Corrosion Comparative Example 9A The procedure described in Example 9 was repeated with the solutions in Table 8 below. These solutions did not contain any azoles. The results are also shown in Table 6.

Table 6 Observation Observation Solution Initial solution after 14 Daysafter 8 Months De-ionized water Coupon Clear, Colorless Corroding,Corroding,No Trace Solution SedimentsSediments 1% by weight of Clear, Colorless Solution Solution With SolutionSedimentsSedimentsdidecyldimethylammonium chloride1 1%1%by weight of ammoniated Dark Blue and copper quat, type D2Clear Solution; Brown Coupon; Dark Sediments;& White Sediment; Clear Solution CorrosionCouponBad Corroding 1% by weight of HazyLiquid;Liquid; Clear, Colorless didecyldimethyl ammonium Lots of Lots of Solution Sedimentcarbonate3Sediment 1% by weight of alkyl (C12-C16) ClearSolution;Clear,Colorless benzyldimethyl ammonium Corrosion Solution Trace Sediments chloride4 '-Didecyldimethyl ammonium chloride is available as Bardac# 2280 from Lonza Inc.

2-Ammoniated copper quat, type D, is available from Chemical Specialties, Inc. of Charlotte, NC. It is prepared following the procedure described in"American Wood- Preservers'Association Standard", published by American Wood Preservers Association, pages 12-13 (1999).

3-Didecyldimethyl ammonium carbonate is prepared according to the procedure described in WO 94/28715.

4 - Alkyl (C12-CI6) benzyldimethyl ammonium chloride is available as Barquat# 80-28 from Lonza Inc.

Example 10 The efficacy of the aqueous amine oxide solutions in Table 7 at various concentrations against the wood rot fungi T. versicolor (white rot fungi), G. trabeum (brown rot fungi), P. placenta (brown rot fungi), and C. globosum (soft rot decay fungi) were determined using the agar dilution plate method well known in the art. The minimum concentration of each amine oxide required to achieve 100% growth retardation of each specific organism, i. e., the minimum inhibitory concentration (MIC), was determined. The percent retardation of the fungi was determined bv the percentage change in the diameter of the fungi on the agar plate (i. e. Percent Retardation = ( (Diameter of Control)- (Diameter of Treated Fungi))/ (Diameter of Control) * 100%).

The results are shown in Table 7 below.

Table 7 MIC (ppm of amine oxides) Amine Oxide T. versicolor G. trabeum P. placenta C. globosum (ppm) (ppm) (ppm) (ppm) Octyldimethylamine 750 1000 1000 >1000 oxide Decyl-DMAO 750 250 500 >1000 Coco-DMAO 750 500 500-1000 >1000 Branched alkyl (C, o- 500 250 500 >1000 Cl4) DMAO Dodecyl-DMAO 250 250 250 >1000 Tetradecyl-DMAO >1000 >1000 >1000 >1000 Hexadecyl-DMAO >1000 >1000 >1000 >1000 Oleyl-DMAO >1000 >1000 >1000 >1000 Octadecyl-DMAO >1000 >1000 >1000 >1000 Behenyl DMAO > 1000 >1000 >1000 >1000 Coco-500 500 500 >1000 di (hydroxyethyl)- amine oxide Tallow->1000 >1000 >1000 >1000 di (hydroxyethyl)- amine oxide Dodecyl-BMAO >1000 1000 >1000 >1000 Lauryl morpholine N-750 1000 500 >1000 oxide The minimum concentration of the aqueous amine oxide solutions in Table 8 required to achieve 50% growth retardation of each specific organism, i. e., IC50, was estimated from the data obtained using Table2D curve fitting. The results are shown in Table 8.

Table 8 Fungi Barloxs 12 BarloxX 12i Bardace 2280 IC50 MIC IC50 MIC IC50 MIC (ppm) (ppm) (ppm) (ppm) (ppm) (ppm) T. versicolor 51 750 84 500 28 >1000 G.trabeum 9 500 44 250 8 >1000 P. placenta 5 1000 89 500 <5 1000 C. globosum 47 >1000 153 >1000 28 >1000 Barlox# 12 is an aqueous solution containing 30% by weight of coco-DMAO.

Barloxs 12i is an aqueous solution containing 30% by weight of branched (C, o-C, 4) alkyl- DMAO. Bardac'2280 is an 80% (w/w) aqueous solution of didecyldimethyl ammonium chloride and is available as Bardac 2280 from Lonza Inc.

The IC50 and MIC concentrations in Tables 7 and 8 above are in ppm of amine oxides and didecyldimethyl ammonium chloride.

Example 11 The efficacy of the aqueous azole solutions in Table 9 at various concentrations against the wood rot fungi T. versicolor (white rot fungi), G. trabeum (brown rot fungi), P. placenta (brown rot fungi), and C. globosum (soft rot decay fungi) were determined using the agar dilution plate method well known in the art. The minimum concentration of each azole required to achieve 100% growth retardation of each specific organism, i. e., the minimum inhibitory concentration (MIC), was determined. The minimum concentration of each azole required to achieve 50% growthretardationofeachspecificorganism, i. e., IC50, was estimated from the data obtained using Table2D curve fitting. The percent retardation of the fungi was determined by the percentage change in the diameter of the fungi on the agar plate (i. e.

Percent Retardation = ( (Diameter of Control)- (Diameter of Treated Fungi))/ (Diameter of Control) * 100%).

The results are shown in Table 9 below.

Table 9 T versicolor G. trabeum P. placenta C. globosum Azole IC50 MIC IC50 MIC IC50 MIC IC50 MIC (ppm) (ppm) (ppm) (ppm) (ppm) (ppm) (ppm) (ppm) Cyproconazole 0. 2 2. 5 0. 3 2. 5 0. 7 2. 5 2. 3 25 250.3503.92510.750Fenbuconazole1.1 Myclobutanil6504. 3>501350->50 Propiconazole 3 50 0. 9 >50 0. 7 50 11. 7 >50 25<0.1101.75034.550-500Tebuconazole2.3 Example 12 The efficacy of aqueous propiconazole/amine oxide solutions containing the amine oxides in Table 10 against the wood rot fungi T. versicolor (white rot fungi), G. trabeum (brown rot fungi), P. placenta (brown rot fungi), and C. globosum (soft rot decay fungi) were determined using the agar dilution plate method well known in the art. Each solution was tested at dilutions of 0.5,5,50, and 250 ppm of propiconazole. The weight ratio of amine oxide to azole was about 20: 1 in each solution. The percent retardation of the fungi was determined by the percentage change in the diameter of the fungi on the agar plate (i. e.

Percent Retardation = ( (Diameter of Control)- (Diameter of Treated Fungi))/ (Diameter of Control) * 100%).

The results are shown in Table 10 below.

Table 10 Concentration Percent Retardation Amine Oxide of Propiconazol P.C.G. e (ppm) Versicolor trabeum placenta globosum Octyldimethylamine 250 100 100 100 100 oxide 50 100 100 100 100 5 100 89 100 85 6962420.511 Decyl-DMAO 250 100 100 100 100 50 100 100 100 100 5 100 100 100 81 6971460.519 Dodecyl-DMAO 100100100100 10010010050100 5 100 100 100 81 0.5 49 71 69 45 Branched250100100100100(C10-C14) DMAO 50 100 100 100 100 5 100 100 100 100 0.5 29 61 60 48 Coco-DMAO 250 100 100 100 100 50 100 100 100 90 5 100 100 100 84 0.5 13 72 76 52 Tetradecyl-DMAO 250 100 100 100 84 50 100 100 100 83 5 87 86 100 80 0.5 5 64 73 51 Hexadecyl-DMAO 250 100 100 100 86 50 100 100 100 85 5 89 85 100 81 0.5 15 68 81 51 Octadecyl-DMAO 250 100 100 100 97 50 100 100 100 89 5 91 85 100 77 0.5 16 61 60 48 Oleyl-DMAO 250 100 100 100 83 50 100 86 100 83 5 90 83 100 70 0.5 50 59 63 31 Behenyl-DMAO 250 100 100 100 97 50 100 100 100 88 8510073586 Concentration Percent Retardation Amine Oxide of Propiconazol e (ppm) Versicolor trabeum placenta globosum 0.5 11 61 55 42 Coco-di (hydroxyethyl) 250 100 100 100 100 amine oxide 50 100 100 100 88 5 100 86 100 71 0.50.5 19 68 61 44 Tallow-250 100 100 100 87 di (hydroxyethyl) amine 50 100 87 100 86 5 100 85 100 76 oxide 0. 5 28 67 65 51 Cetyl morpholine 10010010086250 1001008450100 oxide 5 87 81 100 63 0.5 160.5 16 62 69 4 Didodecyl methyl amine 250 100 100 100 100 oxide 50 100 100 100 81 5 94 84 100 71 0.50.5 14 58 74 43 Dodecyl-BMAO 250 100 100 100 97 50 100 100 100 90 5 88 82 100 71 0.50.5 36 68 64 41 Lauryl morpholine 250 100 100 100 100 N-oxide 50 100 100 100 85 5 100 84 100 66 0.5 34 68 72 30 Octyl-BMAO 250 100 100 100 97 10010010050100 5 100 100 100 88 0.5 13 67 65 48 Didecyldimethyl 250 100 100 100 100 50 100 100 100 86 ammoniumchloride 82100805100 0. 5 39 68 83 66 250 100 100 100 100 50 10086100 (Bardap# 26 76100835100 0.5 40 70 81 65 Example 13 The procedure described in Example 12 was repeated with the aqueous tebuconazole/amine oxide solutions in Table 11.

The results are shown in Table 11 below.

Table 11 Concentration of Percent Retardation Amine Oxide Tebuconazole (ppm) Versicolor trabeum placenta globosum Octyldimethylamine 250 100 100 100 100 oxide 50 100 100 100 100 5 100 100 100 56 7647280.581 Decyl-DMAO 250 100 100 100 100 50 100 100 100 100 5 100 100 100 58 8257220.581 Dodecyl DMAO 250 100 100 100 100 50 100 100 100 83 5 100 100 100 70 0.567847115 Branched alkyl (C, o- 250100100100100 10010010050100 C14) DMAO 5 100 100 100 74 0.50.5 70 83 43-7 Coco-DMAO 250 100 100 100 100 50 100 100 100 79 5 100 100 100 63 0.5 62 86 72 23 Tetradecyl-DMAO 250 100 100 100 78 50 100 100 100 76 5 100 100 100 58 0.5 200.5 20 81 72 29 Hexadecyl-DMAO 250 100 100 100 83 50 100 100 100 81 5 100 100 100 44 0.5 650.5 65 85 72 33 Octadecyl-DMAO 250 100 100 100 100 50 100 100 100 82 5 100 100 100 3 7851210.558 Concentration of Percent Retardation Amine Oxide Tebuconazole P.C.T.G. Versicolor trabeum placenta globosum Oleyl-DMAO 250 100 100 100 79 50 95 100 100 74 5 88 100 100 51 0.5 48 82 56 34 Behenyl-DMAO 250 100 100 100 100 50 100 100 100 82 5 100 100 100-8 0.5 58 82 47-26 Tallow-250 100 100 100 78 di (hydroxyethyl) amine 50 100 100 100 78 5 86 100 100 45 oxide 0. 5 46 85 70 25 Cetyl morpholine N-250 100 100 100 76 oxide 50 100 100 100 74 5 100 100 100 51 0.5 71 83 69 10 Dodecyl-BMAO 250 100 100 100 77 50 100 100 100 76 5 93 100 100 56 0.5 56 84 68 21 Lauryl morpholine N-250 100 100 100 100 oxide 50 100 100 100 82 5 100 100 100 57 0.5 65 84 73 8 Octyl-BMAO 250 100 100 100 100 50 100 100 100 100 5 95 100 100 53 79540.517 Example 14 The procedure described in Example 12 was repeated with the aqueous cyproconazole/amine oxide solutions in Table 12.

The results are shown in Table 12 below.

Table 12 Concentration of Percent Retardation Amine Oxide Cyproconazole (ppm) T G. P. C. Versicolor trabeum placenta globosum Coco-DMAO 50 100 100 100 100 25100100100100 5 100 100 100 74 0. 5 26 73 24 17 Example 15 The procedure described in Example 12 was repeated with the aqueous fenbuconazole/amine oxide solutions in Table 13.

The results are shown in Table 13 below.

Table 13 Concentration of Percent Retardation Amine Oxide Fenbuconazole T. G. P. C. Versicolor trabeum placenta globosum Coco-DMAO 100 100 100 100 100 50 100 100 100 100 5 100 100 100 73 0.5 49 77 65 40 Example 16 The procedure described in Example 11 was repeated with the aqueous myclobutanil/amine oxide solutions in Table 14.

The results are shown in Table 16 below.

Table 14 Concentration of Percent Retardation Amine Oxide Myclobutanil (ppm) T G. P. C. Versicolor trabeum placenta globosum Coco-DMAO 100 100 100 100 86 50 100 100 100 84 5100100 10064 7462260.575 Example17 The procedure described in Example 11 was repeated with the aqueous triadimefon/amine oxide solutions in Table 15.

The results are shown in Table 15 below.

Table 15 Concentration Percent Retardation Amine Oxide of Triadimefon P.C.T.G. (ppm) Versicolor trabeum placenta globosum Octyl-DMAO 250 100 100 100 100 50 100 100 100 80 5 90 86 100 56 0.5 21 73 45 17 Coco-DMAO 250 100 100 100 88 50 100 100 100 75 5 100 100 100 53 0.5 21 76 59 16 Branched alkyl 100100100100250 DMAO 50 100 100 100 100 5 100 100 100 40 0.5 18 62 36-17 Hexadecyl-DMAO 250 100 100 100 77 50 100 100 100 69 5 89 85 100 56 0.5 20 71 71 41 Cetyl morpholine N-250 100 100 100 72 oxide 50 100 100 100 69 5 100 87 100 36 0.5 15 57 54 13 Example 18 Synergism for the aqueous propiconazole/amine oxide solutions in Table 16 against T. Versicolor and G. trabeum were calculated by the methods described in C. E. Kull et al.,"Mixtures of Quaternary Ammonium Compounds and Long-chain Fatty Acids as Antifungal Agents",. 4pplied Microbiology, 9: 538-541 (1961). The synergism value (QA/Qa + QB/Qb) was determined. QA is the concentration of amine oxide (in ppm) in an amine oxide/azole mixture, which yielded 100% retardation of a specific wood rot organism. Qa is the concentration of amine oxide alone (in ppm) required to yield 100% retardation of a specific wood rot organism. QB is the concentration of azole (in ppm) in an amine oxide/azole mixture, which yielded 100% retardation of a specific wood rot organism. Qb is the concentration of azole alone (in ppm) required to yield 100% retardation of a specific wood rot organism. All of the amine oxide/azole solutions in Table 19 exhibited 100% retardation of the specified wood rot organism.

When the value of (QA/Qa + QB/Qb) is less than one, the mixture is synergistic.

Values for (QA/Qa + QB/Qb) of 1 and greater than 1, represent an additive effect and an antagonistic effect, respectively.

Qa for coco-DMAO, decyl-DMAO, branched alkyl (Clo-C, 4)-DMAO, and dodecyl-DMAO against T. versicolor were determined to be 750,750,500, and 250 ppm, respectively. Qa for coco-DMAO, decyl-DMAO, branched alkyl (Clo-Cl4)-DMAO, and dodecyl-DMAO against G. Trabeum were determined to be 500,250,250, and 250 ppm, respectively. Qa for decyl-DMAO, branched alkyl (Clo-Cl4)-DMAO, and dodecyl-DMAO against P. placenta were determined to be 500,500, and 250 ppm, respectively. Qb for propiconazole against T. versicolor, G. trabeum, and P. placenta were all determined to be 50 ppm.

Table 16 Concentratio Concentration QA/Qa + QB/Qb QA/Qa + QB/Qb Amine Oxide n of Amine of (for T. (for G. Oxide (ppm) Propiconazole vesicolor) trabeum) (ppm) 250 0.55 250 0.51 200 5 0.37 0.50 200 1 0.29 0.42 125 5 0.27 0.35 125 0.30 50 10 0.27 0.30 Coco-DMAO 50 0.5 0.08 0.11 25 10 0.23 0.25 25 5 0.13 0.15 25 0.10 12.5 0.08 10 25 0.51 0.52 5 25 0.51 0.51 Decyl-DMAO 100 5 0.23 0.5 Branched Alkyl 100 5 0.30 0.5 (C, o-C, 4)- DMAO Dodecyl-DMAO 100 50. 50 0.5 The aqueous propiconazole/amine oxide solutions in Table 17 below were tested against P. placenta. The results are shown in Table 17 below.

Table 17 Amine Oxide Concentration of Concentration of QA/Qa + QB/Qb (for Amine Oxide Propiconazole P. Placenta) (ppm) (ppm) Decyl-DMAO 100 5 0.3 Branched Alkyl (C, o- 1005 0.3 C,4)-DMAO Dodecyl-DMAO 100 5 0. 5 Example 19 The procedure described in Example 18 was repeated for the aqueous tebuconazole/amine oxide solutions in Tables 18 and 19. The results are shown in Tables 18 and 19.

Qa for coco-DMAO, branched alkyl (Clo-Cl4)-DMAO, decyl-DMAO, dodecyl- DMAO, tetradecyl-DMAO, hexadecyl-DMAO, octadecyl-DMAO, behenyl-DMAO, octyl- DMAO, and lauryl morpholine N-oxide against T. versicolor were determined to be 750,500, 750,250,1000,1000,1000,1000,750, and 750. Qa for coco-DMAO, branched alkyl (Clo- Cl4)-DMAO, decyl-DMAO, and dodecyl-DMAO against G. trabeum were determined to be 500,250,250, and 250 ppm, respectively and Qa for tetradecyl-DMAO, hexadecyl-DMAO, octadecyl-DMAO, behenyl-DMAO, octyl-DMAO, and lauryl morpholine N-oxide were all determined to be 1000 ppm. Qa for decyl-DMAO, dodecyl-DMAO, and lauryl morpholine N-oxide against P. placenta were determined to be 500,250, and 500 ppm, respectively, and Qa for tetradecyl-DMAO, hexadecyl-DMAO, octadecyl-DMAO, behenyl-DMAO, and octyl- DMAO were all determined to be 1000 ppm. Qb for tebuconazole against T. versicolor, G. trabeum, and P. placenta were determined to be 25,10, and 50 ppm, respectively.

Table 18 Concentratio Concentration QA/Qa + QB/Qb QA/Qa + QB/Qb Amine Oxide n of Amine of (for T. (for G. Oxide (ppm) Tebuconazole vesicolor) trabeum) (ppm) 500 0. 1 0. 67 1. 01 200 1 0. 31 0. 50 125 5 0. 37 0.75 100 5 0. 33 0.70 Coco-DMAO 0.170.301001 10 10 0. 41 1.02 5 5 0. 21 0.51 0.5 5 0. 20 0.50 250 0. 25 0. 51 1.03 125 5 0. 45 1.00 100 5 0. 40 0.90 BranchedAlkyl 100 1 0.24 0.50 (C10-C14)- 0.090.20251 DMAO 10 10 0. 42 1.04 5 5 0. 21 0.52 2.5 2. 5 0. 11 0.26 Decyl-DMAO 100 5 0. 33 0.9 Dodecyl-DMAO 100 5 0. 60 0.9 Tetradecyl-100 5 0. 30 0.6 DMAO Hexadecyl-100 5 0. 30 0.6 DMAO Octadecyl-100 5 0. 30 0.6 DMAO 50.300.6Behenyl-DMAO100 Octyl-DMAO 100 5 0. 33 0.6 Lauryl 100 5 0. 33 0. 6 The aqueous solutions in Table 19 below were tested against P. placenta. The results are shown in Table 19 below.

Table 19 Amine Oxide Concentration of Concentration of QA/Qa + QB/Qb (for AmineOxide Tebuconazole P. Placenta) (ppm) (ppm) Decyl-DMAO 100 5 0.3 Dodecyl-DMAO 100 5 0. 5 Tetradecyl-DMAO 100 5 0.2 Hexadecyl-DMAO 100 5 0.2 Octadecyl-DMAO 100 5 0.2 Behenyl-DMAO 100 5 0.2 Octyl-DMAO 100 5 0.2 Lauryl morpholine N-100 5 0. 3 oxide Example 20 The efficacy of the aqueous azole/amine oxide solutions in Table 20 were tested by the procedure described in Example 12. All of these compositions exhibited 100% retardation of T. versicolor, G. trabeum, and P. placenta.

Table 20 Amine Oxide Azole Concentration of Concentration of Amine Oxide Azole (ppm) (ppm) Coco-DMAO Triadimefon 100 5 Branched Alkyl Triadimefon 100 5 (Clo-Cl4)-DMAo Cetyl morpholine Tebuconazole 100 5 N-oxide Octylbenzylmethyl Propiconazole 100 5 amine oxide Example 21 The waterproofing efficacy of the azole/amine oxide solutions in Table 21 on ponderosa pine end-grain wafers (5"x 0.75" x 0.25") was determined as follows. The sample wafers were equilibrated at ambient conditions before treating and were weighed. The samples were then placed in a vacuum desiccator equipped with an addition funnel and evacuated to a pressure (vacuum) of 0. 1 atmosphere for 15 minutes. The treating solution was added to the sample and the pressure in the desiccator increased to atmospheric. The samples were allowed to remain in the solution for five minutes, then removed, blotted, and allowed to air dry to constant weight.

The samples were weighed and immersed in deionized water for about 30 minutes. The samples were removed, surface water was blotted and the samples were weighed and the weight percent of water absorbed was calculated for each sample.

Waterproofing ability is judged by the amount of water that is absorbed by a wooden specimen on immersion for a given time in water. Waterproofing index numbers (WR Index) were calculated by comparing a treated sample with a matched untreated control specimen using the following equation: WR Index = f% Uptake Untreated Control-% Uptake Treated Sample] x 100 % Uptake Untreated Control Any positive index number indicates a degree of waterproofing for the composition. Higher numbers are better than low numbers. A formulation that totally prevents water absorption would have a rating of 100. For certain millwork applications, an index of 60 is required.

The results are shown in Table 21 below.

Table 21 No. Amine Oxide Azole Weight Ratio % Water WR of Amine Uptake Index Oxide to Azole 1 Coco-DMAO Propiconazole 20 26. 65 56 2 Branched alkyl (ClO-cl3) DMAO Propiconazole 20 28.64 53 3 Tetradecyl-DMAO Propiconazole 20 31. 70 48 4 Hexadecyl-DMAO Propiconazole 20 14. 49 76 5* Octadecyl-DMAO Propiconazole 20 14. 68 76 6* Behenyl-DMAO Propiconazole 20 13. 09 79 7 Dodecylbenzylmethyl amine Propiconazole 20 34.81 43 oxide 8 Tallow-di (hydroxyethyl) amine Propiconazole 20 15.97 74 oxide 9 Didecyldimethylammonium Propiconazole 20 39.22 36 chloride (control) 10 Cetyl morpholine N-oxide Propiconazole 20 26.41 57 11 Oleyl-DMAO Propiconazole 20 31. 15 49 12* Didecylmethyl amine oxide Propiconazole 20 21.76 64 13 Hexadecyl-DMAO Tebuconazole 20 16.16 74 14* Octadecyl-DMAO Tebuconazole 20 16. 91 72 15* Behenyl-DMAO Tebuconazole 20 11. 92 80 16 Tallow-di (hydroxyethyl) amine Tebuconazole 20 17.14 72 oxide 17 Cetyl morpholine N-oxide Tebuconazole 20 24.25 60 18 Oleyl-DMAO Tebuconazole 20 31. 62 48 19 Hexadecyl-DMAO Triadimefon 20 17. 59 71 20* Octadecyl-DMAO Triadimefon 20 17. 81 71 21 Cetyl morpholine N-oxide Triadimefon 20 17.09 72 22* Didodecylpiperazine di-N-oxide Triadimefon 20 23.99 61 23 Deionized Water (Control) None N/A 61.00 N/A *-The solution is milky.

All patents, applications, articles, publications, and test methods mentioned above are hereby incorporated by reference.

Many variations of the present invention will suggest themselves to those skilled in the art in light of the above detailed description. Such obvious variations are within the full intended scope of the appended claims.